Koyfin Home > Directory > Health Care > Aclaris Therapts > EV / EBITDA (ntm)

Aclaris Therapts EV / EBITDA (ntm) Chart (ACRS)

Aclaris Therapts annual/quarterly EV / EBITDA (ntm) from 2019 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Aclaris Therapts EV / EBITDA (ntm) for the quarter ending May 05, 2020 was 0.36 a -37.19% decrease of -0.13 year over year
  • Aclaris Therapts EV / EBITDA (ntm) for the last 12 months ending May 05, 2020 was 0.36 a -37.19% decrease of -0.13 year over year
  • Aclaris Therapts Annual EV / EBITDA (ntm) for 2020 was 0.36 a -34.09% decrease of -0.12 from 2019
  • Aclaris Therapts Annual EV / EBITDA (ntm) for 2020 was 0.48 a 9.24% increase of 0.04 from 2019
  • Aclaris Therapts Annual EV / EBITDA (ntm) for 2020 was 0.44 a -12.73% decrease of -0.06 from 2019
Other Valuation Metrics:
  • Aclaris Therapts Market Cap for the quarter ending March 03, 2018 was $541m a -33.92% decrease of -184m year over year
  • Aclaris Therapts Price / Book for the quarter ending March 03, 2018 was 2.40 a -83.99% decrease of -2.02 year over year
  • Aclaris Therapts Enterprise Value for the quarter ending March 03, 2018 was $348m a -64.40% decrease of -224m year over year
View Chart On Koyfin

Quarterly ACRS EV / EBITDA (ntm) Data

05/20200.36
05/20200.48
05/20200.44
05/20200.49
05/20200.50
04/20200.40
04/20200.35
04/20200.50
04/20200.54
04/20200.68

Annual ACRS EV / EBITDA (ntm) Data

20200.36
20200.48
20200.44
20200.49
20200.50
20200.40
20200.35
20200.50
20200.54
20200.68